Literature DB >> 1611189

Two cases of hypothyroidism associated with alpha-interferon therapy.

Y Taniguchi1, T Murakami, K Nakanishi, M Tamai, B Matsuura, T Masumoto, M Onji, J Tajiri, S Noguchi, Y Ohta.   

Abstract

Alpha-interferon was used for anti-cancer or anti-viral therapy in two patients with preexisting autoimmune thyroid disease and in seven patients with chronic viral hepatitis who had no history of thyroid dysfunction. Primary hypothyroidism developed in the two patients who had a history of autoimmune thyroid disease, while no changes in thyroid function were observed in the other seven patients. Modulation of the immune system by alpha-interferon may have been responsible for the development of hypothyroidism in these two patients. Therefore, autoantibodies to the thyroid and the thyroid function should be assessed in patients undergoing alpha-interferon therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1611189     DOI: 10.2169/internalmedicine.31.373

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  [Interferon therapy and autoimmunity].

Authors:  J Fritzsch; J Krug; H J Heberling
Journal:  Med Klin (Munich)       Date:  1997-05-15

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

3.  Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon.

Authors:  T Kodama; S Katabami; K Kamijo; A Katanuma; K Yamashita; N Azuma; T Tamaki; A Yachi
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.